03/01
Headlines

OGXI

Healthcare Decliners: SunLink Health Systems, Inc. (NYSEMKT:SSY), Recro Pharma Inc (NASDAQ:REPH), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Retrophin Inc (NASDAQ:RTRX)

Richard Atkins03 mins

SunLink Health Systems Inc. (NYSEMKT:SSY) said that net loss for the third-quarter ended March 31, 2014 widened to $964,000 or $0.10 per share, from $186,000 or $0.02 per share last year. Loss from continuing operations for the quarter was $911,000 or $0.10 per share, compared to a loss from continuing operations of $197,000 or $0.02…

Read More

Biotech Early Movers: OncoGenex Pharmaceuticals Inc(NASDAQ:OGXI), Agenus Inc(NASDAQ:AGEN), Athersys, Inc.(NASDAQ:ATHX)

Colin Pettis03 mins

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) shares plunged more than 48% pre-market after the company said results from its Phase 3 SYNERGY trial to add custirsen to standard first-line treatment of docetaxel/prednisone in men with metastatic prostate cancer failed to meet primary endpoints. The stock which was halted from trading ahead of the news, recently changed hands…

Read More